Why should we use convalescent plasma for COVID-19?

Subjects

Subjects :

2019-20 coronavirus outbreak
Convalescent plasma
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Pneumonia, Viral
Treatment outcome
Article
Passive immunotherapy
Betacoronavirus
Internal Medicine
Humans
Medicine
Viral therapy
Pandemics
COVID-19 Serotherapy
SARS-CoV-2
business.industry
Passive Immunotherapy
Immunization, Passive
COVID-19
Viral Load
Treatment Outcome
Immunology
Coronavirus Infections
business

Details

ISSN :

09536205

Volume :

77

Database :

OpenAIRE

Journal :

European Journal of Internal Medicine

Accession number :

edsair.doi.dedup.....73a88a24a9f7dd553881f373367ff2fe